Philip Howe to Neoplasms
This is a "connection" page, showing publications Philip Howe has written about Neoplasms.
Connection Strength
1.131
-
TGF-beta signaling in cancer: post-transcriptional regulation of EMT via hnRNP E1. Cytokine. 2019 06; 118:19-26.
Score: 0.268
-
EMT does not work regular shifts. Cell Cycle. 2018; 17(2):141-142.
Score: 0.267
-
Discovery of a metastatic pathway: implications for future cancer treatment. Future Oncol. 2011 Jun; 7(6):703-5.
Score: 0.169
-
Identification of an mRNP complex regulating tumorigenesis at the translational elongation step. Mol Cell. 2011 Feb 18; 41(4):419-31.
Score: 0.166
-
RNA binding protein PCBP1 is an intracellular immune checkpoint for shaping T cell responses in cancer immunity. Sci Adv. 2020 05; 6(22):eaaz3865.
Score: 0.079
-
The Long (lncRNA) and Short (miRNA) of It: TGF?-Mediated Control of RNA-Binding Proteins and Noncoding RNAs. Mol Cancer Res. 2018 04; 16(4):567-579.
Score: 0.068
-
3'-UTR-mediated post-transcriptional regulation of cancer metastasis: beginning at the end. RNA Biol. 2011 Jul-Aug; 8(4):595-9.
Score: 0.042
-
Wnt signaling: physiology and pathology. Growth Factors. 2004 Sep; 22(3):141-50.
Score: 0.026
-
Secreted transforming growth factor beta2 activates NF-kappaB, blocks apoptosis, and is essential for the survival of some tumor cells. Proc Natl Acad Sci U S A. 2004 May 04; 101(18):7112-7.
Score: 0.026
-
The role of disabled-2 (Dab2) in diseases. Gene. 2021 Feb 15; 769:145202.
Score: 0.020